Lee Chun Feng, Ling Zhi Qiang, Zhao Ting, Fang Shih Hua, Chang Weng Cheng, Lee San Chih, Lee Kuan Rong
Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan, China.
World J Gastroenterol. 2009 Jan 21;15(3):356-65. doi: 10.3748/wjg.15.356.
To identify the genes related to lymph node metastasis in human hepatocellular carcinoma (HCC), 32 HCC patients with or without lymph node metastasis were investigated by high-throughput microarray comprising 886 genes.
The samples of cancerous and non-cancerous paired tissue were taken from 32 patients with HCC who underwent hepatectomy with lymph node dissection. Total RNA was extracted from the cells obtained by means of laser microdissection (LCM) and was amplified by the T7-based amplification system. Then, the amplified samples were applied in the cDNA microarray comprising of 886 genes.
The results demonstrated that 25 up-regulated genes such as cell membrane receptor, intracellular signaling and cell adhesion related genes, and 48 down-regulated genes such as intracellular signaling and cell cycle regulator-related genes, were correlated with lymph node metastasis in HCC. Amongst them were included some interesting genes, such as MET, EPHA2, CCND1, MMP2, MMP13, CASP3, CDH1, and PTPN2. Expression of 16 genes (MET, CCND1, CCND2, VEGF, KRT18, RFC4, BIRC5, CDC6, MMP2, BCL2A1, CDH1, VIM, PDGFRA, PTPN2, SLC25A5 and DSP) were further confirmed by real-time quantitative reverse transcriptional polymerase chain reaction (RT-PCR).
Tumor metastasis is an important biological characteristic, which involves multiple genetic changes and cumulation. This genome-wide information contributes to an improved understanding of molecular alterations during lymph node metastasis in HCC. It may help clinicians to predict metastasis of lymph nodes and assist researchers in identifying novel therapeutic targets for metastatic HCC patients.
为了鉴定与人类肝细胞癌(HCC)淋巴结转移相关的基因,我们采用包含886个基因的高通量微阵列对32例有或无淋巴结转移的HCC患者进行了研究。
从32例行肝切除术及淋巴结清扫术的HCC患者中获取癌组织和癌旁配对组织样本。通过激光显微切割(LCM)获得细胞,提取总RNA,并采用基于T7的扩增系统进行扩增。然后,将扩增后的样本应用于包含886个基因的cDNA微阵列。
结果表明,25个上调基因,如细胞膜受体、细胞内信号传导和细胞黏附相关基因,以及48个下调基因,如细胞内信号传导和细胞周期调节相关基因,与HCC的淋巴结转移相关。其中包括一些有趣的基因,如MET、EPHA2、CCND1、MMP2、MMP13、CASP3、CDH1和PTPN2。通过实时定量逆转录聚合酶链反应(RT-PCR)进一步证实了16个基因(MET、CCND1、CCND2、VEGF、KRT18、RFC4、BIRC5、CDC6、MMP2、BCL2A1、CDH1、VIM、PDGFRA、PTPN2、SLC25A5和DSP)的表达。
肿瘤转移是一种重要的生物学特性,涉及多个基因变化和累积。这些全基因组信息有助于更好地理解HCC淋巴结转移过程中的分子改变。它可能有助于临床医生预测淋巴结转移,并协助研究人员为转移性HCC患者确定新的治疗靶点。